Rony Dahan

9PUBLICATIONS
75CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 05, 2026
Fc-optimized GITR antibody enhances a CD4 T cell-dendritic cell crosstalk to promote antitumor immunity.

|Jan 28, 2025
Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma.

Sapir Cohen Shvefel, Joy A Pai, Yingying Cao

|Dec 23, 2024
Temporal genomic analysis of homogeneous tumor models reveals key regulators of immune evasion in melanoma.

Sapir Cohen Shvefel, Joy A Pai, Yingying Cao

|Mar 01, 2024
Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocols.

Oren Barboy, Akhiad Bercovich, Hanjie Li

|Dec 26, 2023
FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment.

David A Knorr, Lucas Blanchard, Rom S Leidner

|Mar 03, 2023
Fc glycoengineering of a PD-L1 antibody harnesses Fcγ receptors for increased antitumor efficacy.

Noy Cohen Saban, Adam Yalin, Tomer Landsberger

Pageof 2

Frequent Collaborators

4 joint publications

Ido Amit

2 joint publications

Ran Salomon

2 joint publications

Yingying Cao

2 joint publications

Noy Cohen Saban